Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 229 followers
Latest posts
Last updated about 5 hours ago
STAT+: HaloMD’s legal win highlights the difficulty of challenging arbitration decisions
about 5 hours ago
Arbitration decisions, it turns out, are like cockroaches. They’re very hard to...
Trump taps former public health leader Erica Schwartz to run CDC
about 7 hours ago
President Trump nominated Erica Schwartz on Thursday to be director of the...
A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
about 7 hours ago
On this week’s episode of the Readout LOUD: a pancreatic cancer breakthrough...
STAT+: Kennedy focuses on affordability, combating fraud in Capitol Hill hearing
about 8 hours ago
WASHINGTON — Health Secretary Robert F. Kennedy Jr. returned to Capitol Hill...
STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
about 10 hours ago
The scientists whose work spurred the development of powerful obesity drugs like...
Cochrane review reignites Alzheimer’s amyloid wars
about 11 hours ago
Want to stay on top of the science and politics driving biotech...
RFK Jr. begins his testimony marathon
about 12 hours ago
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about...
STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more
about 13 hours ago
Top of the morning to you. And a fine one it is...
STAT+: Medicare may nix breakthrough device payment pathway
about 13 hours ago
You’re reading the web edition of STAT’s Health Tech newsletter, our guide...
The mental health parity gap is gaping
about 14 hours ago
Get your daily dose of health and medicine every weekday with STAT’s...
STAT+: Roche to launch another Elevidys trial, with eyes on European approval
about 16 hours ago
In an attempt to win European approval for the controversial medicine, Roche...
STAT+: Travere’s drug for a kidney disease doesn’t improve kidney function. The FDA approved it anyway
about 16 hours ago
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter...